Drug Information Rounds

Annals of Pharmacotherapy

Volumn 30, Issue 12, 1996, Pages 1481-1483

  Denzel, Debbie ^a   Burstein, Aaron H ^b  

^a Rocky Mt Drug Consultation Center   (United States)

^b UNIVERSITY OF MARYLAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE DERIVATIVE; DIAZEPAM; LORAZEPAM; MIDAZOLAM; PENTETRAZOLE; PHENOBARBITAL; PHENYTOIN; ANTICONVULSIVE AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CONVULSION; DRUG COST; DRUG HALF LIFE; EPILEPTIC STATE; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MOUSE; NONHUMAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; ANIMAL; DRUG RESISTANCE; PATHOPHYSIOLOGY;

ANIMALS; ANTICONVULSANTS; DRUG RESISTANCE; HUMANS; INFUSIONS, INTRAVENOUS; MIDAZOLAM; STATUS EPILEPTICUS;

EID: 0030446365     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1177/106002809603001217     Document Type: Article

References (17)

1. Working Group on Status Epilepticus. Treatment of convulsive status epilepticus. Recommendations of the Epilepsy Foundation of America's working group on status epilepticus. JAMA 1993;270:854-9.
2. Treiman DM. The role of benzodiazepines in the management of status epilepticus. Neurology 1990;40(suppl 2):3242.
3. Jagoda A, Riggio S. Refractory status epilepticus in adults. Ann Emerg Med 1993;22:1337-48.
4. Bell HE, Bertino JS. Constant diazepam infusion in the treatment of continuous seizure activity. Drug Intell Clin Pharm 1984;18:965-70.
5. Labar DR, Ali A, Root J. High-dose intravenous lorazepam for the treatment of refractory status epilepticus. Neurology 1994;44:1400-3.
6. Raines A, Henderson TR, Swinyard EA, Dretchen KL. Comparison of midazolam and diazepam by the intramuscular route for the control of seizures in a mouse model of status epilepticus. Epilepsia 1990;31:313-7.
7. Jawad S, Oxley J, Wilson J, Richens A. A pharmacodynamic evaluation of midazolam as an antiepileptic compound. J Neurol Neurosurg Psych 1986;49:1050-4.
8. Galvin GM, Jelinek GA. Midazolam: an effective intravenous agent for seizure control. Arch Emerg Med 1987;4:169-72.
9. Rivera R, Segnini M, Baltodano A, Perez V. Midazolam in the treatment of status epilepticus in children. Crit Care Med 1993;21:991-4.
10. Crisp CB, Gannon R, Knauft F. Continuous infusion of midazolam hydrochloride to control status epilepticus. Clin Pharm 1988;7:322-4.
11. Kumar A, Bleck TP. Intravenous midazolam for the treatment of refractory status epilepticus. Crit Care Med 1992;20:483-8.
12. Parent JM, Lowenstein DH. Treatment of refractory generalized status epilepticus with continuous infusion of midazolam. Neurology 1994;44:1837-40.
13. McEvoy GK, ed. American hospital formulary service drug information 96. Bethesda, MD: American Society of Hospital Pharmacists, Inc. 1996:1709-15.
14. Louis S, Kutt H, McDowell F. The cardiocirculatory changes caused by intravenous dilantin and its solvent. Am Heart J 1967;74:523-9.
15. Al-Khudhairi D, Whitwan JG. Autonomic reflexes and the cardiovascular effects of propylene glycol. Br J Anaesth 1986;58:897-902.
16. Midazolam. In: Olin BR, ed. Facts and comparisons monthly update. St Louis, MO: JB Lippincott Co, 1995:281f-i.
17. 1996 Drug topics red book. Montvale, NJ: Medical Economics Co, Inc, 1996.